Cargando…
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showi...
Autores principales: | Hecht, Robert, Hiebert, Lindsey, Spearman, Wendy C, Sonderup, Mark W, Guthrie, Teresa, Hallett, Timothy B, Nayagam, Shevanthi, Razavi, Homie, Soe-Lin, Shan, Vilakazi-Nhlapo, Kgomotso, Pillay, Yogan, Resch, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894072/ https://www.ncbi.nlm.nih.gov/pubmed/29529282 http://dx.doi.org/10.1093/heapol/czy018 |
Ejemplares similares
-
Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
por: de Villiers, Margaret J., et al.
Publicado: (2020) -
The impact of the timely birth dose vaccine on the global elimination of hepatitis B
por: de Villiers, Margaret J., et al.
Publicado: (2021) -
The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
por: Schmit, Nora, et al.
Publicado: (2020) -
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
por: Heffernan, Alastair, et al.
Publicado: (2019) -
Digital health in South Africa: innovating to improve health
por: Pillay, Yogan, et al.
Publicado: (2018)